Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) 18.3% LOWER; intends to offer shares of common stock in a public offering. H.C. Wainwright & Co., LLC will serve as the sole book runner for the offering. While the offering is expected to price before 9:30 am EST on March 4, 2015, the offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Bob Evans Farms (NASDAQ: BOBE) 17.9% LOWER; reported Q3 EPS of $0.60, $0.10 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $367.2 million versus the consensus estimate of $358.83 million. Bob Evans Farms sees FY2015 EPS of $1.40-$1.60, versus the consensus of $1.97.
TriNet Group (NYSE: TNET) 15.5% LOWER; reported Q4 EPS of $0.26, may not compare to the analyst estimate of $0.37. Revenue for the quarter came in at $603.7 million, versus $481.66 million reported last year.
NeoPhotonics (NYSE: NPTN) 14.3% HIGHER; reported Q4 EPS of $0.19, $0.24 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $79 million versus the consensus estimate of $77.3 million.
Career Education (NASDAQ: CECO) 13% HIGHER; reported Q4 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $174.2 million versus the consensus estimate of $232.51 million.
Bazaarvoice (NASDAQ: BV) 11.8% LOWER; reported Q3 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $49.6 million versus the consensus estimate of $49.34 million.
Veeva Systems (NYSE: VEEV) 9.3% LOWER; reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $87 million versus the consensus estimate of $85.37 million. Veeva Systems sees Q1 2016 EPS of $0.10, versus the consensus of $0.09. Veeva Systems sees Q1 2016 revenue of $87-88 million, versus the consensus of $87.7 million. Veeva Systems sees FY2016 EPS of $0.43-$0.45, versus the consensus of $0.41. Veeva Systems sees FY2016 revenue of $390-395 million, versus the consensus of $392.1 million.
Smith & Wesson (NASDAQ: SWHC) 8.8% HIGHER; reported Q3 EPS of $0.20, $0.14 better than the analyst estimate of $0.06. Revenue for the quarter came in at $130.6 million versus the consensus estimate of $116.98 million. Smith & Wesson sees Q4 2015 EPS of $0.29-$0.31, versus the consensus of $25.00. Smith & Wesson sees Q4 2015 revenue of $163-166 million, versus the consensus of $159.4 million. Smith & Wesson sees FY2015 EPS of $0.87-$0.89, versus the consensus of $0.70. Smith & Wesson sees FY2015 revenue of $532-536 million, versus the consensus of $526.9 million.
Amarin Corp plc (NASDAQ: AMRN) 7.1% HIGHER; reported Q4 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $17.4 million.
TiVo (NASDAQ: TIVO) 6.5% HIGHER; reported Q4 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $91.7 million versus the consensus estimate of $89.03 million.
Ambarella (NASDAQ: AMBA) 5.5% HIGHER; reported Q4 EPS of $0.68, $0.19 better than the analyst estimate of $0.49. Revenue for the quarter came in at $64.7 million versus the consensus estimate of $59.4 million.
Achillion Pharmaceuticals (NASDAQ: ACHN) 3% LOWER; Barclays initiated coverage with an Underweight rating
GoPro, Inc. (NASDAQ: GPRO) 2.5% HIGHER; up on strong results from supplier Ambarella
ZELTIQ Aesthetics (NASDAQ: ZLTQ) 2.3% HIGHER; reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $50.8 million versus the consensus estimate of $50.7 million.
